Pricing

Maxygen Inc (MAXY)

followers ·
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
515 GALVESTON DRIVE REDWOOD CITY, CA 94063

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Maxygen, Inc. (Maxygen) is a biotechnology company focused on the development of its MAXY-G34 product candidate. MAXY-G34 is a pegylated, granulocyte colony stimulating factor (G-CSF), for the treatment of chemotherapy-induced neutropenia and acute radiation syndrome (ARS). On May 16, 2011, Astellas Pharma Inc. (Astellas) acquired the Companys interests in Perseid Therapeutics LLC, the Companys former subsidiary, which included all of the Companys research and development operations. As a result of the transaction, the Company has reclassified the operating results of Perseid, as well as any related business activities, to discontinued operations. The Companys wholly owned subsidiaries include Maxygen Holdings (U.S.), Inc., Maxygen ApS and Maxygen Holdings, Inc., and its majority owned subsidiary, Maxygen Holdings LLC.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available